Coloplast A/S (CLPBY)
7.26
+0.02
(+0.28%)
USD |
OTCM |
Aug 25, 16:00
Coloplast Net Income (Quarterly) : 227.46M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 227.46M |
| March 31, 2026 | -152.06M |
| December 31, 2025 | 217.72M |
| September 30, 2025 | 137.01M |
| June 30, 2025 | 122.28M |
| March 31, 2025 | 128.67M |
| December 31, 2024 | 149.30M |
| September 30, 2024 | 193.48M |
| June 30, 2024 | 183.86M |
| March 31, 2024 | 182.25M |
| December 31, 2023 | 174.77M |
| September 30, 2023 | 179.38M |
| June 30, 2023 | 185.83M |
| March 31, 2023 | 166.50M |
| December 31, 2022 | 154.45M |
| September 30, 2022 | 166.54M |
| June 30, 2022 | 184.40M |
| March 31, 2022 | 147.76M |
| December 31, 2021 | 185.49M |
| September 30, 2021 | 206.84M |
| June 30, 2021 | 203.30M |
| March 31, 2021 | 183.01M |
| December 31, 2020 | 181.96M |
| September 30, 2020 | 163.43M |
| June 30, 2020 | 147.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 157.33M |
| December 31, 2019 | 161.82M |
| September 30, 2019 | 118.14M |
| June 30, 2019 | 160.72M |
| March 31, 2019 | 155.33M |
| December 31, 2018 | 151.54M |
| September 30, 2018 | 162.10M |
| June 30, 2018 | 151.56M |
| March 31, 2018 | 151.51M |
| December 31, 2017 | 148.69M |
| September 30, 2017 | 159.51M |
| June 30, 2017 | 134.74M |
| March 31, 2017 | 133.46M |
| December 31, 2016 | 137.04M |
| September 30, 2016 | 63.58M |
| June 30, 2016 | 148.44M |
| March 31, 2016 | 135.37M |
| December 31, 2015 | 121.03M |
| September 30, 2015 | -211.82M |
| June 30, 2015 | 105.10M |
| March 31, 2015 | 122.98M |
| December 31, 2014 | 133.78M |
| September 30, 2014 | 149.52M |
| June 30, 2014 | 145.06M |
| March 31, 2014 | -3.486M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ambu A/S | 18.95M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.144B |
| Total Expenses (Quarterly) | 916.84M |
| EPS Diluted (Quarterly) | 0.1009 |
| Enterprise Value | 18.57B |
| Gross Profit Margin (Quarterly) | 66.73% |
| Profit Margin (Quarterly) | 19.88% |
| Earnings Yield | 2.63% |
| Operating Earnings Yield | 7.12% |
| Normalized Earnings Yield | 4.747 |